Crossmark

Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon α-2b for 48 weeks

Published Online: 2024-12-19

Published Print: 2025-04

Authors

Tan, Zhili

Kong, Nan

Zhang, Qiran

Gao, Xiaohong

Shang, Jia

Geng, Jiawei

You, Ruirui

Wang, Tao

Guo, Ying

Wu, Xiaoping

Zhang, Wenhong

Qu, Lihong

Zhang, Fengdi https://orcid.org/0000-0002-5732-188X
Funding

Funding for this research was provided by:

Shanghai Pudong New Area Health Commission (PW2021A-14)

Shanghai Pudong New Area Health Commission (PDZY-2024-0702)
License Information

Text and Data Mining valid from 2024-12-19

Version of Record valid from 2024-12-19
More Information

Article History

Received: 13 September 2024

Accepted: 29 November 2024

First Online: 19 December 2024

Declarations

:

: All authors declare no conflict of interest.

: The experimental protocol was allowed by the ethics committee of Shanghai East Hospital, Tongji University School of Medicine.

Document is current